A carregar...
Bortezomib may Stabilize Pediatric Renal Transplant Recipients with Antibody-Mediated Rejection
BACKGROUND: Current therapeutic strategies to effectively treat antibody-mediated rejection (AMR) are insufficient. Thus, we aimed to determine the benefit of a therapeutic protocol using bortezomib for refractory C4d+ AMR in pediatric kidney transplant patients. METHODS: We examined 7 patients with...
Na minha lista:
| Publicado no: | Pediatr Nephrol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5590841/ https://ncbi.nlm.nih.gov/pubmed/27048228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-016-3319-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|